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Abstract
In this paper we revisit the Mackey-Glass model for blood-forming
process, which was proposed to describe the spontaneous fluctuations of
the blood cell counts in normal individuals and the first stage of chronic
myelocytic (or granylocytic) leukemia (CML). We obtain the bifurcation
diagram as a function of the time delay parameter and show that the
onset of leukemia is related to instabilities associated to the presence of
periodic windows in the midst of a chaotic regime. We also introduce a
very simple modification in the death rate parameter in order to simulate
the accumulation of cells and the progressive increase of the minima counts
experimentally observed in the final stage of the disease in CML patients.
The bifurcation diagram as a function of the death rate parameter is also
obtained and we discuss the effects of treatments like leukapheresis.
1 Introduction
Many years ago Mackey and Glass [1] proposed two different simple models to
describe chronic and acute diseases, generated by the failure of physiological
control systems, which may be identified by the altered periodicity of some
observable. Recently Landa and Rosemblum [2] revisited one of the models
proposed to describe the respiration control and introduced a modification in
the original equation in order to take into account the activity of the brain
on respiration. In this paper we revisit the model proposed to describe the
fluctuations in the blood cell counts in normal individuals and the initial phase
of chronic myelocytic leukemia (CML).
The human blood contains a remarkable variety of cells, each type precisely
designed to its own vital function. All different types of blood cells are produced
in the bone marrow and all of them are originated from earlier non-functional
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cells called stem cells. The stem cells replicate repeatedly and differentiate into
various kind of secondary cells. The growth and development of cells in the
bone marrow are carefully controlled to produce the correct number of each
type of cell necessary to keep the body healthy. The blood-forming process
(hematopoiesis) is subjected to active control by mechanisms acting to buffer
the system against disturbances and to provide adaptive adjustment to non-
stationary conditions [3]. The hematopoiesis is regulated by feedback control
systems and as other time-delayed processes [4, 5] it exhibits oscillatory and
cyclic behaviors.
Most of the models proposed to describe physiological control systems con-
sider the differentiation steps of the secondary cells as different compartments
described by differential equations. In general those models have a high-dimensional
parameter space ([6]- [8]) which makes it quite difficult to compare theoretical
results to the experimental ones. In contrast to those more realistic, but rather
complicated models, Mackey and Glass [1] proposed a very simple model based
on a single time-delayed differential equation, with parameters estimated from
experimental data. The change of the time delay parameter leads to different
kind of oscillations of the cell counts which may be associated to healthy and
non-healthy behaviors when compared to experimental data obtained by Gatti
et al [9]. The onset of an abnormal dynamics, which may be associated to the
onset of leukemia is then obtained in this model by the gradual tuning of a con-
trol (time-delay) parameter. Since its proposal this model has been mostly used
as a paradigm for non-linear systems ([10]- [14]),and less attention was paid to
its biological applications.
In this paper, we show that this simple model that generates very complex
dynamical behaviors for cell counts, is more robust than thought to reproduce
the onset of leukemia and it is also possible to use it to reproduce the two phases
of leukemia and the effects of some treatments. The observed instabilities that
occur at the onset of leukemia can be obtained for different values of the time
delay parameter, corresponding to different possibilities of the system to achieve
the edge of chaos. In other words, the instabilities resulting from complex
interactions involved in the physiological control systems that may describe the
oscillations observed in CML patients correspond to an state hovering between
the incoherence of chaos and the spontaneous order found in periodic behaviors
([15]).
In section 2 we present the biological motivation that inspired the model dis-
cussed here and other experimental data concerning the discussions we present
along the paper. In section 3 we introduce the model. In section 4 we present
the results obtained. We first obtain the bifurcation diagram in function of
the time delay parameter for the Mackey-Glass model and show that the onset
of leukemia is related to instabilities associated to transition regions between
chaotic and periodic regimes, usually refereed in the literature as the edge of
chaos. These transition regions occur for a set of different values of the time-
delay parameter and not only for a unique value of this parameter. The bifur-
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cation sequence observed in this diagram is quite uncommon and presents only
some of the periods suggested by the authors [1, 5]. We also introduce a simple
modification in the death rate parameter of this model in order to simulate the
progressive increase of the minima counts in phase II of CML. The bifurcation
diagram in function of the death rate parameter is also obtained and the effects
of leukapheresis treatments is also discussed. Our conclusions are summarized
in section 5.
2 The Biological Motivation
It has been observed spontaneous fluctuations with periodic behavior in the pe-
ripheral blood cell counts of healthy individuals, in chronic myelocytic leukemia
(CML) patients [16, 17] as well as in other pathological states [5]. In healthy in-
dividuals constant or mild oscillations of the peripheral-blood leukocyte-counts
occur with periods varying from 14 to 24 days [16], while in many patients with
CML these oscillations have periods varying from 30 to 120 days ([16, 18]), with
a cell accumulation process observed in the final stage (phase II) of the disease.
Morley et al [16] suggested that in patients with cyclic leukocytosis and CML,
the bone marrow is either unduly sensitive to feedback stimulus or being excited
intermittently by an abnormal stimulus, generated outside the marrow.
From long term observations Gatti et al. [9] showed that the onset of
leukemia (CML) is characterized by two distinct phases: phase I, a stable 15-
month period, from time of diagnosis, during which leukocyte counts peaked
every 72 days and then returned to the baselines level; and phase II, a 18-
month period during which the minima levels of leukocyte counts became pro-
gressively higher indicating that those cells were accumulating in the peripheral
blood. According to them, the increased marrow production in the disease does
not represent a life-threatening situation, until cell accumulation begins. Dur-
ing phase I, the leukocyte counts return to baseline levels, indicating that the
overproduction of cells in the peak of a given cycle could be cleared from the
peripheral blood before the beginning of the next cycle. In contrast, in phase
II, the leukocytes accumulate in the peripheral blood of the patient, suggesting
primarily an increase in the cell production or a progressive loss of cell-clearing
capacity with little or no changes in the production capacity [9].
Patients with CML were submitted to leukapheresis treatments in order to
test out if this kind of treatment would be able to reverse the rising leukocyte
levels providing a good therapy to maintain the patient healthy for years. The
leukapheresis consists of 8 weeks of intense treatment to remove about 30−50%
of the mature and premature leukocytes from marrow and peripheral blood.
According to the results obtained [9], those treatments are able to retrieve the
system from the behavior of phase II to the behavior observed in phase I, with
low amplitude cycles and minima counts. However, after one year, subsequent
cycles (of 72 days each) indicated re-accumulation of cells in the peripheral
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blood. In other words, these studies clearly demonstrated that leukapheresis is
effective for the rapid reduction of elevated cell counts, but long-term treatment
has not improved survival of the patients with CML, since this kind of treatment
do not alter the mechanisms underlying the disease process.
Nowadays this kind of treatment is not used anymore, and have been replaced
by other treatments like chemotherapy and radiotherapy that in some cases
may lead to the patient cure. The mechanisms underlying the effectiveness
(or not) of those modern treatments are not clear-they act by producing an
intense immunosupression followed by an intense activation of the bone marrow
in order to recover the system, involving different kinds of drugs- and it would
be impossible to discuss its effects on this very simple model. However, it is
possible to analyze and simulate the effects of leukapheresis in the MG model
as will be shown in section 4.
3 The Model
The Mackey-Glass model [1] relates the number of precursor and mature cells
resident on the bone marrow to the number of cells released into the blood
stream. The time evolution of an homogeneous population of mature, circulating
cells of density P is then given by:
dP (t)
dt
=
β0θ
nPτ
θn + Pn
τ
− γP (t) (1)
where the first term in the right hand side corresponds to the cellular produc-
tion, which is described by a (Hill) function of Pτ = P (t−τ), where τ represents
the delay between the production of the precursor cells and the release of the
mature cells into the blood. The average (density independent) death rate of
the population is given by γ. The constant values of β0, θ, n and γ are estimated
from experimental data [1].
Like other theoretical models ([6]-[8]), the Mackey-Glass model associates
the onset of cyclic leukocytosis and leukemia with instabilities in the dynamics
of the model. They found that for τ = 6 days the solution has low amplitude
oscillations with period of 20 days, which describes qualitatively the mild oscil-
lations observed in the circulating levels of leukocytes in normal healthy adults
[16]. For τ = 20, the numerical solution reproduces the altered periodicity ob-
served in phase I of the diagram of circulating leukocytes as a function of time
of patients with diagnosed CML [9].
4 Results
By standard fourth-order Runge-Kutta integration techniques the numerical
solution for the equation is obtained, where we adopt the same set of parameters
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of the original model [1]. In order to characterize the dynamical instabilities
associated to the onset of leukemia we have obtained the bifurcation diagram of
the local maxima of the time evolution of P (t) as a function of the time delay
parameter τ as shown in figure 1. This diagram was built from the analysis
of the cross section of the return map for different values of τ . By increasing
the time-delay parameter the oscillations become unstable and new cycles with
different periods appear, leading to aperiodic and then to chaotic behavior.
In contrast with the findings of Mackey-Glass, we found a quite uncommon
bifurcation sequence: 1, 2, 3, 6, 7, 14, etc. with windows of period 6 and 9 in
the midst of the aperiodic regime. We also note the appearance of a branch of
sparse points just above τ = 17. This branch persists when we vary the initial
conditions.
We have observed that the very same altered periodicity observed for τ = 20
(which was associated to the onset of the cyclic leukocytosis by Mackey and
Glass [1]) could also be reproduced for other values of τ , for instance, τ = 18.6
and 21.2. The common feature among these values of the time delay parameter
is that they correspond to the edge of the periodic windows which appear in
the midst of aperiodic regime. This indicates the robustness of the model to
describe the disturbances that would correspond to the onset of leukemia.
In this model, the regular behavior of the blood-forming process and the
pathological states of disease correspond to different attractors of the dynam-
ics. The standard methods of characterization of the attractors can be applied
for small values of τ (periodic behavior), whose attractors have low embedding
dimension, and for large values of this parameter (chaotic behavior), whose em-
bedding dimension of the attractors can be approximated to infinity, for which
simple asymptotic solutions exist [10, 11]. Nevertheless, for intermediate val-
ues of this parameter the attractors are embedded in a high-dimensional space
and the characterization becomes quite difficult, specially in cases like this one,
which involves time-delayed information. As far as we know up to now the
available techniques do not allow a precise characterization of the dynamics
for intermediate values of τ . In figure 2 we show the power spectra for four
values of τ corresponding to the three different dynamical behaviors described
above. Our results indicate that the special values corresponding to the onset
of leukemia would correspond to a quasi-periodic behavior: the power spec-
trum has numerous peaks and presents a slow decay to zero. This behavior
should correspond to the zero value of the Lyapunov exponent. Nevertheless,
because of the difficulties mentioned above, the calculations performed are still
not conclusive.
As mentioned before, the phase II of the common pattern observed in CML
patients may be associated to either a failure of the cell-clearing capacity of the
system or a over-production of immature cells (the cells lose the ability to mature
and differentiate) which leads to the accumulation of cells and to a progressive
increase of the minima counts in the leukocyte population [9]. In order to
simulate the phase II, we introduce a simple modification to the death rate
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that would correspond to a failure in the cell-clearing capacity. Modifications in
the cell production, in order to simulate the loss of the cell’s ability to mature
and differentiate is not straightforward and will be discussed elsewhere. The
different dynamical behaviors observed in the two distinct phases, will be related
to changes in the death rate, since in phase II it will be no longer constant. The
death rate γ will be described during phase II by a step function that diminishes
by 10−4 every 60 days. This simple modification simulates a system that slowly
loses the ability to remove cells, and reproduces qualitatively the increase of the
minima counts, observed by Gatti et al [9] in phase II of the disease, as shown
in figure 3. We have also tried other possible functions, but this one was more
appropriate to describe the accumulation of cells observed in phase II.
Figure 3 is obtained for the same set of parameters used in the original
model. We have arbitrarily chosen to let the system evolve with γ constant
until t = 4900 (which would correspond to the end of phase I) and after this
point the death rate begins to decrease. The slope of the linear growth of
the minima counts in our simulations has the same order of magnitude as the
equivalent slope in the experimental data.
In figure 4 we present the bifurcation diagram as a function of γ, for τ = 20,
in the range of interest. The diagram shows a bifurcation sequence which ends
up in a limited region from 0.08 to 0.12 of aperiodic behavior, above which the
system becomes periodic again. In the midst of the aperiodic region we also
find windows of periodicity 6.
We also simulate the effects of leukapheresis treatments during the phase II.
We let the system evolve during some time (600 days) in phase II and then we
simulate the first leukapheresis, in order to test if this cleaning procedure would
revert the raising of the minima counts. The treatment is simulated maintaining
the density of cells constant during 60 days (equivalent to the 8 weeks of real
treatment) in a level that corresponds to 60% of the value of the density in the
beginning of the protocol [19]. For τ = 20, after 60 days the system does not
have memory of what happened before the treatment. After each treatment
we let the system evolve under the same conditions, since the treatment only
removes the excess of cells accumulated and do not interferes on the underlying
mechanisms that could generate the disturbance. Just after the treatment the
minima counts returned to the baseline levels, but after a while we have observed
the same linear increase of the minimal counts of phase II, as in the experimental
data. The numerical solutions obtained for two leukapheresis treatments with
approximately one year interval (400 days) between each other is shown in figure
5. The results show a good qualitative agreement with the experimental results
[9]. Before the first treatment and between the two treatments γ is practically
constant (varies approximately from 0.1 to 0.099), maintaining itself in the
aperiodic region of the γ-bifurcation diagram , with no change of attractor (see
figure 4).
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5 Conclusions
The Mackey-Glass model for the blood-forming process reproduces the main
features observed in the peripheral blood-cell counts for normal individuals and
pathologies like cyclic leukocytosis and the disorder that characterizes the ac-
cumulation of cells observed in a patient diagnosed with leukemia (CML) in
phase I and II. We have shown that the onset of leukemia is related to special
intermediate values of the time-delay parameter, which seem to correspond to
quasi-periodic behaviors. From the bifurcation diagram as a function of the
time-delay parameter τ , we observed that the onset of leukemia is associated
to the edge of periodic windows in the midst of aperiodic behavior. By varying
the death rate parameter we could reproduce the phase II behavior observed in
the experimental data, and with a simple cell-removing procedure we simulated
the effects of leukapheresis. We have also obtained the bifurcation diagram as
a function of the death rate γ.
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Figure 1: Bifurcation diagram as a function of the time delay parameter τ , for
the Mackey-Glass time delayed differential equation using β0 = 0.2 per day,
θ = 1.6× 10−6, n = 10 and γ = 0.1.
9
10−6
10−5
10−4
10−3
10−2
10−1
100
τ=6.0
10−6
10−5
10−4
10−3
10−2
10−1
100
τ=18.6
102 103 104 105
10−6
10−5
10−4
10−3
10−2
10−1
100
τ=20.0
102 103 104 105
10−6
10−5
10−4
10−3
10−2
10−1
100
τ=100.0
Figure 2: Power spectra of the numerical solutions of the MG equation for
periodic (τ = 6), quasi-periodic (τ = 18.6 and τ = 20) and chaotic (τ = 100)
regimes.
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Figure 3: Numerical solution showing qualitative behavior very similar to phases
I and II of leukemia [9].
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Figure 4: Bifurcation diagram as a function of γ, obtained for the same set of
parameters of figure 1, for τ = 20.
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Figure 5: Simulation of two Leukapheresis (I and II) considering the same set
of parameters of figure 1, with a time interval of 400 days between the two
treatments. Since the disturbance continues to act after the treatment, after
some time we observe the same increase of the minima densities, as observed in
the experimental data shown in figure 1 of ref. 9.
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